Form 4 for RPRX Royalty Pharma plc
Accepted 2025-12-17 00:00:00 ET · period of report 2025-12-15 · accession 0001814876-25-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-17 | 2025-12-15 | RPRX | Coyne Terrance P. | EVP, CFO | S - Sale | $38.36 | -69.6K | 526.7K | -12% | -$2.67M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2025-12-15 | S | D | 3,750 | $38.36 | 43,510 | I TPC RP EPA1 LLC | — | — | (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.10 to $38.48 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Class A Ordinary Shares | 2025-12-15 | S | D | 65,832 | $38.36 | 526,660 | I By TPC RP 2021, LLC | — | — | (F2) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.10 to $38.48 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |